Amarin Corp PLC (AMRN)
0.7963
+0.01
(+0.64%)
USD |
NASDAQ |
Jul 26, 16:00
0.7963
0.00 (0.00%)
After-Hours: 20:00
Amarin Max Drawdown (5Y): 97.40% for June 30, 2024
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
Date | Value |
---|---|
June 30, 2024 | 97.40% |
May 31, 2024 | 97.26% |
April 30, 2024 | 97.26% |
March 31, 2024 | 97.26% |
February 29, 2024 | 97.26% |
January 31, 2024 | 97.26% |
December 31, 2023 | 97.26% |
November 30, 2023 | 97.26% |
October 31, 2023 | 97.16% |
September 30, 2023 | 96.50% |
August 31, 2023 | 95.81% |
July 31, 2023 | 95.56% |
June 30, 2023 | 95.56% |
May 31, 2023 | 95.56% |
April 30, 2023 | 95.56% |
March 31, 2023 | 95.56% |
February 28, 2023 | 95.56% |
January 31, 2023 | 95.56% |
December 31, 2022 | 95.56% |
November 30, 2022 | 95.56% |
October 31, 2022 | 95.56% |
September 30, 2022 | 95.48% |
August 31, 2022 | 95.32% |
July 31, 2022 | 95.32% |
June 30, 2022 | 95.32% |
Date | Value |
---|---|
May 31, 2022 | 95.32% |
April 30, 2022 | 88.85% |
March 31, 2022 | 88.18% |
February 28, 2022 | 87.60% |
January 31, 2022 | 87.60% |
December 31, 2021 | 86.57% |
November 30, 2021 | 85.24% |
October 31, 2021 | 84.91% |
September 30, 2021 | 84.91% |
August 31, 2021 | 84.91% |
July 31, 2021 | 84.91% |
June 30, 2021 | 84.91% |
May 31, 2021 | 84.91% |
April 30, 2021 | 86.16% |
March 31, 2021 | 87.26% |
February 28, 2021 | 90.17% |
January 31, 2021 | 90.37% |
December 31, 2020 | 92.87% |
November 30, 2020 | 93.49% |
October 31, 2020 | 93.49% |
September 30, 2020 | 93.49% |
August 31, 2020 | 93.49% |
July 31, 2020 | 93.49% |
June 30, 2020 | 93.49% |
May 31, 2020 | 93.49% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
84.91%
Minimum
May 2021
97.40%
Maximum
Jun 2024
92.97%
Average
94.82%
Median
Max Drawdown (5Y) Benchmarks
Trinity Biotech PLC | 96.69% |
Cellectis SA | 97.08% |
Akari Therapeutics PLC | 98.58% |
Biodexa Pharmaceuticals Plc | 100.00% |
Verona Pharma PLC | 89.71% |
Max Drawdown (5Y) Related Metrics
Alpha (5Y) | -76.04 |
Beta (5Y) | 1.952 |
Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 74.60% |
Historical Sharpe Ratio (5Y) | -0.6818 |
Historical Sortino (5Y) | -1.099 |
Monthly Value at Risk (VaR) 5% (5Y Lookback) | 38.53% |